These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19289638)

  • 1. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
    Eisenberg MJ; Richard PR; Libersan D; Filion KB
    Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
    Kimura T; Morimoto T; Nakagawa Y; Tamura T; Kadota K; Yasumoto H; Nishikawa H; Hiasa Y; Muramatsu T; Meguro T; Inoue N; Honda H; Hayashi Y; Miyazaki S; Oshima S; Honda T; Shiode N; Namura M; Sone T; Nobuyoshi M; Kita T; Mitsudo K;
    Circulation; 2009 Feb; 119(7):987-95. PubMed ID: 19204304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries.
    Artang R; Dieter RS
    Am J Cardiol; 2007 Apr; 99(8):1039-43. PubMed ID: 17437724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment.
    Airoldi F; Colombo A; Morici N; Latib A; Cosgrave J; Buellesfeld L; Bonizzoni E; Carlino M; Gerckens U; Godino C; Melzi G; Michev I; Montorfano M; Sangiorgi GM; Qasim A; Chieffo A; Briguori C; Grube E
    Circulation; 2007 Aug; 116(7):745-54. PubMed ID: 17664375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late and very late stent thrombosis in patients with second-generation drug-eluting stents.
    Huang KN; Grandi SM; Filion KB; Eisenberg MJ
    Can J Cardiol; 2013 Nov; 29(11):1488-94. PubMed ID: 23830291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focused clinical review: periprocedural management of antiplatelet therapy in patients with coronary stents.
    Bell B; Layland J; Poon K; Spaulding C; Walters D
    Heart Lung Circ; 2011 Jul; 20(7):438-45. PubMed ID: 21493140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
    Cross J
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation.
    Latib A; Morici N; Cosgrave J; Airoldi F; Godino C; Brambilla N; Chieffo A; Bonizzoni E; Carlino M; Bedogni F; Montorfano M; Sangiorgi GM; Briguori C; Colombo A
    Am J Cardiol; 2008 Dec; 102(11):1477-81. PubMed ID: 19026299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
    Yano M; Natsuaki M; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitsudo K; Kimura T;
    Int J Cardiol; 2015 Nov; 199():296-301. PubMed ID: 26226333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.
    Gurbel PA; DiChiara J; Tantry US
    Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials.
    Généreux P; Rutledge DR; Palmerini T; Caixeta A; Kedhi E; Hermiller JB; Wang J; Krucoff MW; Jones-McMeans J; Sudhir K; Simonton CA; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25940520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy.
    Rizik DG; Klassen KJ
    Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
    Sharma A; Berkeley A
    J Clin Anesth; 2009 Nov; 21(7):517-20. PubMed ID: 20006260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.